Company Profile
180 Life Sciences Stock Price, News & Analysis
- Ticker:
- ATNF
- Exchange:
- NASDAQ
- Sector:
- Life Science Tools
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for ATNF.
Company overview
Business overview
180 Life Sciences is a life-sciences company that has pursued multiple research and platform directions over time. Its identity has been shaped by strategic repositioning rather than a single durable therapeutic franchise.
Geographic Base and Sector Classification
180 Life Sciences is headquartered in the United States and listed on NASDAQ. It sits in life sciences and biotech-adjacent development.
Business Model Characteristics
The company depends on corporate strategy, capital management, and the ability to find a focused pipeline or business model. Investors generally watch restructuring, financing, and program selection.
Position Within the Biotechnology Landscape
180 Life Sciences occupies a strategic-repositioning niche rather than a clear therapeutic franchise. Its stock tends to reflect whether management can sharpen the company's identity.
Future catalysts
180 Life Sciences is now mostly a legacy and closeout story, with catalysts limited to any strategic or asset-resolution update. The market no longer treats it like an active development name.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does 180 Life Sciences do?
180 Life Sciences is a life-sciences company that has pursued multiple research and platform directions over time. Its identity has been shaped by strategic repositioning rather than a single durable therapeutic franchise.
On which exchange is ATNF stock listed?
180 Life Sciences (ATNF) is associated with NASDAQ, United States, Life Science Tools.
What is Life?
180 Life Sciences is now mostly a legacy and closeout story, with catalysts limited to any strategic or asset-resolution update.
Which conditions is 180 Life Sciences targeting with Life?
180 Life Sciences is now mostly a legacy and closeout story, with catalysts limited to any strategic or asset-resolution update.
How does 180 Life Sciences describe recent progress with Life?
180 Life Sciences is now mostly a legacy and closeout story, with catalysts limited to any strategic or asset-resolution update.
What is Sciences?
180 Life Sciences is a life-sciences company that has pursued multiple research and platform directions over time.
What should investors watch for with Sciences?
180 Life Sciences is now mostly a legacy and closeout story, with catalysts limited to any strategic or asset-resolution update.
What future catalysts are investors watching for 180 Life Sciences?
180 Life Sciences is now mostly a legacy and closeout story, with catalysts limited to any strategic or asset-resolution update. The market no longer treats it like an active development name.